Gladys Morrison is a seasoned professional in the field of oncology and clinical development, currently serving as a Scientific Director in Oncology Development at AbbVie. Previously, Gladys held various roles including Associate Director Clinical Scientist and Clinical Scientist II within Oncology Early Development at the same company. Prior experience includes serving as a Translational Scientist in Clinical Development and Operations at Black Diamond Therapeutics and as a Senior Clinical Research member focused on Phase I Developmental Therapeutics at UChicago Medicine. Gladys also contributed as a Research Scientist in Molecular Pharmacology at Aptinyx Inc. and completed a Clinical Pharmacology and Pharmacogenomics Fellowship at the University of Chicago Medicine. Academic credentials include a Doctor of Philosophy (Ph.D.) in Translational Biology and Molecular Medicine from Baylor College of Medicine and a Bachelor of Science (B.S.) in Biochemistry from Spelman College.